Clinical Trials Logo

Filter by:
NCT ID: NCT05097235 Completed - Clinical trials for Sensory Profiles, Nociplastic Pain, Low Back Pain

Type 3 Predictive Observational Study for Sensory Profiles in Central Sensitization in Low Back Pain Population.

T3PredCohSt
Start date: May 1, 2022
Phase:
Study type: Observational [Patient Registry]

This study conducts prognostic research to develop, validate, and evaluate the predictive role of sensory profiles in the development of sensory profiles over time. Therefore, a type 3 prognostic model research will be conducted in the low back pain population.

NCT ID: NCT05090228 Completed - Clinical trials for Pulmonary Valve Insufficiency

Right Ventricle Remodeling After Pulmonary Valve Replacement and Percutaneous Pulmonary Valve Insertion

RV-REPAIR
Start date: February 1, 2016
Phase:
Study type: Observational

This study investigates damage of the right cardiac chamber in adult patients with a congenital heart defect involving the pulmonary valve (the heart valve between the right cardiac chamber and the lungs). The investigators want to investigate if novel, less invasive techniques are feasible to assess damage of this right cardiac chamber, to improve follow-up and timing of intervention (valve replacement) in this group of patients.

NCT ID: NCT05085470 Completed - Schistosomiasis Clinical Trials

Repeated Controlled Human Schistosoma Mansoni Infection

Start date: October 29, 2021
Phase: N/A
Study type: Interventional

A group of 24 healthy volunteers are challenged one or three times with 20 male Schistosoma mansoni cercariae to investigate whether this leads to protection and to identify potential correlates of protection

NCT ID: NCT05084729 Completed - Clinical trials for Breast Abnormality Diagnosis

CONFIDENCE Registry

CONFIDENCE
Start date: September 11, 2020
Phase:
Study type: Observational [Patient Registry]

This registry has been designed to obtain real-life, post-market data on the use of the Imagio breast imaging system. This registry is sponsored by Seno Medical Instruments, Inc., the manufacturer of the device.

NCT ID: NCT05082688 Completed - Influenza Clinical Trials

Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)

Start date: September 20, 2021
Phase: Phase 2
Study type: Interventional

Vaccines are used to prevent infectious diseases worldwide. Unfortunately, many vaccines, like the flu vaccine, are less effective in older adults. This single-centre open label partially randomised, partially placebo-controlled trial evaluates the differences in immune response between young and older adults after vaccination with a quadrivalent inactivated influenza vaccine and an adjuvanted herpes zoster vaccination. Exploring the underlying mechanisms between the differences in immunogenicity can provide important information for future vaccine development.

NCT ID: NCT05079386 Completed - Laryngectomy Clinical Trials

Clinical Feasibility of a New Voice Prosthesis

Start date: January 7, 2022
Phase: N/A
Study type: Interventional

The objective of this clinical investigation is to evaluate the short-term clinical feasibility of a new voice prosthesis and explore its acceptability, limitations and advantages. As a result of the evaluations, design changes may be implemented and evaluated until the optimal design has been determined, or until it is decided not to pursue further development of the device. Main outcome will be the patient's acceptance of the voice prosthesis, secondary outcomes are stickiness of the valve mechanism and speech.

NCT ID: NCT05076422 Completed - Healthy Clinical Trials

A Study to Test How Well Men Tolerate Different Doses of BI 3006337

Start date: October 18, 2021
Phase: Phase 1
Study type: Interventional

The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics of BI 3006337 in healthy male subjects following subcutaneous administration of single-rising doses.

NCT ID: NCT05076149 Completed - Cystic Fibrosis Clinical Trials

A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

Start date: October 27, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants who are homozygous for F508del, heterozygous for F508del and a gating (F/G) or residual function (F/RF) mutation, or have at least 1 other TCR CF transmembrane conductance regulator (CFTR) gene mutation and no F508del mutation.

NCT ID: NCT05071092 Completed - Clinical trials for Cardiovascular Diseases

Dietary Intervention to Improve Health of Cardiovascular Patients

Start date: May 28, 2021
Phase: N/A
Study type: Interventional

Voed je Beter is a randomized, multicenter, controlled trial to examine whether personalized guidance to increase adherence to the Dutch dietary guidelines, compared to usual care, improves health of cardiovascular patients who receive regular medical treatment.

NCT ID: NCT05067647 Completed - Thoracic Procedure Clinical Trials

A Study of the ENSEAL® X1 Curved Jaw Tissue Sealer and Generator G11 in Thoracic, Urologic, and Ear, Nose, and Throat (ENT) Procedures

Start date: November 29, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate the acceptable performance and safety of the ENSEAL X1 curved jaw tissue sealer and Ethicon endo-surgery generator G11 (GEN11) devices when used per the instructions for use (IFU).